In the era of precision medicine and immunotherapy, breakthrough cancer treatments can target the unique molecular characteristics of an individual's cancer. Significant advances have been made for some of the most common cancers.
The question now isn't just what cancer care is available — it's whether patients and their oncologists have access to it. The fact is, community health care providers struggle to keep up with the firehose of new treatments, evolving guidelines and clinical trials. This is where plan sponsors and benefit managers have a critical role. By modernizing plan design, they can broaden participants' access to the latest therapies, minimize time lost to unnecessary treatments, and improve health equity by reducing variation in treatment plans. To learn more, download this practical guide for benefits managers
